Tag: QBiotics Group Limited
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma
MSD collaboration to investigate QBiotics' lead molecule tigilanol tiglate in combination with KEYTRUDA(R) (pembrolizumab)Tigilanol tiglate is a novel, small molecule being developed...
